Biogen Idec Photos

Exterior RTP
Interior RTP
Bird's Eye View

+ Add Photo

Biogen Idec Reviews

Rating Trends
Recommend to a friend
Approve of CEO
Biogen Idec CEO and Director George A. Scangos
George A. Scangos
143 Ratings
  • scientist ii

    Current Employee - Anonymous Employee
    Current Employee - Anonymous Employee

    I have been working at Biogen Idec


    good benefit and good location


    don't know. too early to tell

Biogen Idec Interviews

Interview Experience

Interview Experience


Getting an Interview

Getting an Interview


Interview Difficulty


Interview Difficulty



  1. Helpful (3)  

    Director Interview

    Anonymous Employee in Cambridge, MA
    No Offer
    Negative Experience
    Easy Interview


    I applied in-person. The process took 3+ monthsinterviewed at Biogen Idec (Cambridge, MA).


    Positive phone screen with HR for a position very aligned with my experience; or at least I thought. Came in to interview and spoke with the remote hiring manager by phone. I was disappointed to learn that she'd been in town the week before so that was a missed opportunity for both of us. After that and a meeting with a dotted manager, it seemed to me that they didn't have a clear sense of the job and who they wanted/needed. They asked me questions clearly outside my background which was frustrating (why am here?!) and a little insulting as I'd done similar jobs at 3 major companies. No one offered me their card or said they'd be in touch. (Could you please be just a little less obvious?) HR never followed up with me and ignored my attempt to confirm closure. How rude and arrogant when I'd made the effort to come on site. Wow.

    Interview Questions

    • "This maybe a hard question, but.."   1 Answer

Biogen Idec Awards & Accolades

Something missing? Add an award
Top Employer, Science Magazine, 2012
Top Employer, Science Magazine, 2011
Show More

Additional Info

Unlock Profile
Headquarters Cambridge, MA
Size 5000+ Employees
Founded 1978
Type Company - Public (BIIB)
Industry Biotech & Pharmaceuticals
Revenue $5 to $10 billion (USD) per year
Competitors Unknown

With its pipeline full of biotech drugs, Biogen Idec aims to meet the unmet needs of patients around the world. The biotech giant is focused on developing treatments in the areas of immunology and neurology. Its product roster includes best-selling Avonex, a popular drug for the treatment of relapsing multiple sclerosis (MS); Tysabri, a drug treatment for MS and Crohn's disease (developed with Elan); Rituxan, a monoclonal antibody developed jointly with Genentech that treats non-Hodgkin's lymphoma and rheumatoid arthritis; and Fumaderm, a psoriasis drug marketed in... More

Work at Biogen Idec? Share Your Experiences

Biogen Idec

Click to Rate